Vikas Sinha - Net Worth and Insider Trading
Vikas Sinha Net Worth
The estimated net worth of Vikas Sinha is at least $48 Million dollars as of 2024-05-04. Vikas Sinha is the EVP & CFO of Alexion Pharmaceuticals Inc and owns about 178,463 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $33 Million. Vikas Sinha is the See Remarks, 10% Owner of AlloVir Inc and owns about 17,812,862 shares of AlloVir Inc (ALVR) stock worth over $14 Million. Vikas Sinha is also the Director of Verona Pharma PLC and owns about 74,440 shares of Verona Pharma PLC (VRNA) stock worth over $1 Million. Details can be seen in Vikas Sinha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vikas Sinha has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).
Transaction Summary of Vikas Sinha
Vikas Sinha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vikas Sinha owns 4 companies in total, including AlloVir Inc (ALVR) , Alexion Pharmaceuticals Inc (ALXN) , and BCLS Acquisition Corp (BLSA) among others .
Click here to see the complete history of Vikas Sinha’s form 4 insider trades.
Insider Ownership Summary of Vikas Sinha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALVR | AlloVir Inc | 2024-04-22 | director & 10 percent owner & See Remarks |
| ALXN | Alexion Pharmaceuticals Inc | 2016-08-08 | EVP & CFO |
| BLSA | BCLS Acquisition Corp | 2020-10-22 | director |
 | | 2021-05-04 | director |
Vikas Sinha Latest Holdings Summary
Vikas Sinha currently owns a total of 3 stocks. Among these stocks, Vikas Sinha owns 178,463 shares of Alexion Pharmaceuticals Inc (ALXN) as of August 8, 2016, with a value of $33 Million and a weighting of 67.92%. Vikas Sinha owns 17,812,862 shares of AlloVir Inc (ALVR) as of April 22, 2024, with a value of $14 Million and a weighting of 29.64%. Vikas Sinha also owns 74,440 shares of Verona Pharma PLC (VRNA) as of May 4, 2021, with a value of $1 Million and a weighting of 2.44%.
Latest Holdings of Vikas Sinha
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2016-08-08 | 178,463 | 182.50 | 32,569,498 |
| ALVR | AlloVir Inc | 2024-04-22 | 17,812,862 | 0.80 | 14,214,664 |
| VRNA | Verona Pharma PLC | 2021-05-04 | 74,440 | 15.69 | 1,167,964 |
Holding Weightings of Vikas Sinha
Vikas Sinha Form 4 Trading Tracker
According to the SEC Form 4 filings, Vikas Sinha has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 277 shares on August 8, 2016, which brought Vikas Sinha around $37,988.
According to the SEC Form 4 filings, Vikas Sinha has made a total of 19 transactions in AlloVir Inc (ALVR) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in AlloVir Inc is the sale of 3,378 shares on April 22, 2024, which brought Vikas Sinha around $2,534.
According to the SEC Form 4 filings, Vikas Sinha has made a total of 2 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Verona Pharma PLC is the sale of 10,016 shares on May 4, 2021, which brought Vikas Sinha around $8,413.
Insider Trading History of Vikas Sinha
- 1
Vikas Sinha Trading Performance
Vikas Sinha Ownership Network
Vikas Sinha Owned Company Details
What does AlloVir Inc do?
Who are the key executives at AlloVir Inc?
Vikas Sinha is the director & 10 percent owner & See Remarks of AlloVir Inc. Other key executives at AlloVir Inc include General Counsel Edward Miller , Chief Accounting Officer Brett R Hagen , and 10 percent owner Gilead Sciences Inc .
AlloVir Inc (ALVR) Insider Trades Summary
Over the past 18 months, Vikas Sinha made 14 insider transaction in AlloVir Inc (ALVR) with a net sale of 60,959. Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 174,997 shares made by Diana Brainard , a net sale of 83,530 shares made by Brett R Hagen , and a net sale of 17,662 shares made by Edward Miller .
In summary, during the past 3 months, insiders sold 115,969 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 115,969 shares. During the past 18 months, 403,222 shares of AlloVir Inc (ALVR) were sold and 2,930,870 shares were bought by its insiders, resulting in a net purchase of 2,527,648 shares.
AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.
AlloVir Inc Insider Transactions
Vikas Sinha Mailing Address
Above is the net worth, insider trading, and ownership report for Vikas Sinha. You might contact Vikas Sinha via mailing address: C/o Alexion Pharmacueticals, Inc., 352 Knotter Drive, Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
